Reserveantibiotika in der Milcherzeugung in Deutschland

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

This report finds that approximately 80 percent of dairy cows in Germany receive antibiotics before each calving, with 10 percent of these treatments involving reserve antibiotics like 4th generation cephalosporins, which are critical for human medicine.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Approximately 80 percent of dairy cows in Germany are treated with antibiotics during the 'dry-off' period before the next calf is born. In 2013, over 9.2 million injectors of antibiotic dry-off agents were distributed to veterinarians, treating an estimated 2.94 million cows.
  • Reserve antibiotics, specifically 4th generation cephalosporins, account for 10 percent of antibiotic dry-off treatments in Germany. These substances are classified by the WHO as 'critically important' for human medicine, particularly for treating meningitis and salmonella infections in children.
  • High-performance breeding, which increases milk yield by an average of 100 kg per cow per year, is linked to a rise in udder, hoof, and reproductive organ diseases. Specifically, breeding for higher milk flow per minute (milkability) is linearly associated with a deterioration in udder health due to easier entry of pathogens.
  • The German government's antibiotic database is criticized for gaps, as it does not record antibiotic use in dairy farming and focuses on the frequency of administration rather than the dose. This creates an incentive for farmers to use long-acting reserve antibiotics, which require fewer administrations and thus appear more favorable in the database.
  • Resistance rates for E. coli in dairy cows against Ceftiofur showed a significant increase over a ten-year period, rising from 0% to 9% according to BVL monitoring data from 2002 to 2012.
  • The report identifies economic pressures, such as the milk price crisis where producers receive less than 30 cents per kg despite costs of 40-50 cents, as a driver for using cost-effective reserve antibiotics over more labor-intensive health management.

Cite the original document

APA
Benning, R. (2016). Reserveantibiotika in der Milcherzeugung in Deutschland. Germanwatch. https://www.germanwatch.org/sites/default/files/publication/13987.pdf
Chicago
Benning, Reinhild. Reserveantibiotika in der Milcherzeugung in Deutschland. Germanwatch, 2016. https://www.germanwatch.org/sites/default/files/publication/13987.pdf.
Wikipedia
{{cite report |last1=Benning |first1=Reinhild |title=Reserveantibiotika in der Milcherzeugung in Deutschland |publisher=Germanwatch |date=January 2016 |url=https://www.germanwatch.org/sites/default/files/publication/13987.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document gerwat-000808)}}
BibTeX
@techreport{benning2016reserveantibiotika, author = {Benning, Reinhild}, title = {{Reserveantibiotika in der Milcherzeugung in Deutschland}}, institution = {Germanwatch}, year = {2016}, month = jan, url = {https://www.germanwatch.org/sites/default/files/publication/13987.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document gerwat-000808} }

Full text

Collected · Record updated